Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$42.56 - $59.82 $202,883 - $285,161
4,767 New
4,767 $269,000
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $202,374 - $427,235
6,352 Added 49.11%
19,285 $836,000
Q1 2023

May 11, 2023

SELL
$45.44 - $74.26 $32,353 - $52,873
-712 Reduced 5.22%
12,933 $849,000
Q4 2022

Feb 08, 2023

SELL
$41.39 - $81.0 $498,666 - $975,888
-12,048 Reduced 46.89%
13,645 $613,000
Q3 2022

Nov 09, 2022

SELL
$72.36 - $113.1 $213,606 - $333,871
-2,952 Reduced 10.31%
25,693 $1.86 Million
Q2 2022

Aug 10, 2022

SELL
$87.2 - $114.05 $3.46 Million - $4.52 Million
-39,644 Reduced 58.05%
28,645 $3.07 Million
Q1 2022

May 12, 2022

BUY
$94.19 - $124.49 $4.41 Million - $5.83 Million
46,827 Added 218.19%
68,289 $7.58 Million
Q4 2021

Feb 10, 2022

BUY
$119.57 - $139.07 $1.74 Million - $2.03 Million
14,567 Added 211.27%
21,462 $2.75 Million
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $235,588 - $307,191
2,158 Added 45.56%
6,895 $918,000
Q2 2021

Aug 06, 2021

BUY
$100.34 - $115.69 $18,763 - $21,634
187 Added 4.11%
4,737 $511,000
Q1 2021

May 10, 2021

SELL
$101.51 - $125.27 $84,050 - $103,723
-828 Reduced 15.4%
4,550 $479,000
Q4 2020

Feb 10, 2021

BUY
$85.88 - $105.36 $140,327 - $172,158
1,634 Added 43.64%
5,378 $561,000
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $6,546 - $8,325
-90 Reduced 2.35%
3,744 $321,000
Q2 2020

Aug 10, 2020

BUY
$48.02 - $79.04 $184,108 - $303,039
3,834 New
3,834 $283,000
Q1 2020

May 21, 2020

SELL
$36.95 - $62.95 $137,934 - $234,992
-3,733 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$47.06 - $56.64 $175,674 - $211,437
3,733 New
3,733 $210,000
Q3 2019

Nov 12, 2019

SELL
$47.45 - $58.05 $183,299 - $224,247
-3,863 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$39.26 - $54.21 $151,661 - $209,413
3,863 New
3,863 $210,000
Q1 2018

May 15, 2018

SELL
$39.4 - $47.39 $545,611 - $656,256
-13,848 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $244,379 - $282,082
6,557 Added 89.93%
13,848 $572,000
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $246,071 - $303,815
7,291
7,291 $295,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.